Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Trevitt

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Magnetic Resonance (Gottingen, Germany)|October 31, 2023
High-affinity tamoxifen analogues retain extensive positional disorder when bound to calmodulinLilia Milanesi, Clare R Trevitt, Brian Whitehead, et al.
Antioxidants (Basel, Switzerland)|July 2, 2021
'Carbon-Monoxide-Releasing Molecule-2 (CORM-2)' Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial EffectsHannah M Southam, Michael P Williamson, Jonathan A Chapman, et al.
Chemistry & Biology|January 25, 2005
Enhanced ligand affinity for receptors in which components of the binding site are independently mobileClare R Trevitt, C Jeremy Craven, Lilia Milanesi, et al.
The Journal of Biological Chemistry|April 17, 2009
Conformational properties of beta-PrPLaszlo L P Hosszu, Clare R Trevitt, Samantha Jones, et al.
The Journal of Biological Chemistry|May 5, 2004
The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPCLaszlo L P Hosszu, Graham S Jackson, Clare R Trevitt, et al.
Biochemistry|August 20, 2010
The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like formLaszlo L P Hosszu, M Howard Tattum, Samantha Jones, et al.
Nature Communications|November 3, 2020
Allomorphy as a mechanism of post-translational control of enzyme activityHenry P Wood, F Aaron Cruz-Navarrete, Nicola J Baxter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2009
Crystal structure of human prion protein bound to a therapeutic antibodyS V Antonyuk, C R Trevitt, R W Strange, et al.
Redox Biology|July 16, 2018
A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3Hannah M Southam, Thomas W Smith, Rhiannon L Lyon, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Magnetic Resonance (Gottingen, Germany)|October 31, 2023
High-affinity tamoxifen analogues retain extensive positional disorder when bound to calmodulinLilia Milanesi, Clare R Trevitt, Brian Whitehead, et al.
Antioxidants (Basel, Switzerland)|July 2, 2021
'Carbon-Monoxide-Releasing Molecule-2 (CORM-2)' Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial EffectsHannah M Southam, Michael P Williamson, Jonathan A Chapman, et al.
Chemistry & Biology|January 25, 2005
Enhanced ligand affinity for receptors in which components of the binding site are independently mobileClare R Trevitt, C Jeremy Craven, Lilia Milanesi, et al.
The Journal of Biological Chemistry|April 17, 2009
Conformational properties of beta-PrPLaszlo L P Hosszu, Clare R Trevitt, Samantha Jones, et al.
The Journal of Biological Chemistry|May 5, 2004
The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPCLaszlo L P Hosszu, Graham S Jackson, Clare R Trevitt, et al.
Biochemistry|August 20, 2010
The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like formLaszlo L P Hosszu, M Howard Tattum, Samantha Jones, et al.
Nature Communications|November 3, 2020
Allomorphy as a mechanism of post-translational control of enzyme activityHenry P Wood, F Aaron Cruz-Navarrete, Nicola J Baxter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2009
Crystal structure of human prion protein bound to a therapeutic antibodyS V Antonyuk, C R Trevitt, R W Strange, et al.
Redox Biology|July 16, 2018
A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3Hannah M Southam, Thomas W Smith, Rhiannon L Lyon, et al.
Pageof 3